HUMA · ISSUER CIK 1818382
Humacyte, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Humacyte, Inc. insiders reported $30K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Jones Keith Anthony (Director), with $30K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$30KInsider buying
$0.00Insider selling
+$30KNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202616:05 | Sep 14, 2026 | HUMA | Director | P · Buy | $0.56 | +10,000 | 50,000 | +25% | +$6K | -45.4% | -16.4% |
| Aug 21, 202616:05 | Aug 20, 2026 | HUMA | Director | P · Buy | $0.69 | +10,000 | 40,000 | +33% | +$7K | -53.5% | -32.2% |
| Aug 19, 202616:00 | Aug 17, 2026 | HUMA | Director | P · Buy | $0.59 | +30,000 | 30,000 | New | +$18K | -60.1% | -20.9% |